Skip to main content
SpringerLink
Log in

Zelfzorginterventies bij patiënten met diabetes mellitus type 2

  • Artikel
  • Published:
Bijblijven

Samenvatting

Meer bewegen, minder en gezonder eten, maximeren van alcohol en stoppen met roken leveren patiënten met type-2-diabetes veel gezondheidswinst op. Echter, dit soort ‘actieve’ zelfzorginterventies zijn in de praktijk nogal eens moeilijk haalbaar of moeilijk vol te houden in tegenstelling tot populaire, meer ‘passieve’ zelfzorginterventies als het slikken van chroomsupplementen. Uit de verschillende besproken studies blijkt dat er voor een viertal interventies geen bewijs bestaat aangaande hun effectiviteit, terwijl veel patiënten bereid zijn tijd, moeite en geld in dit soort ‘behandelingen’ te investeren. Er is meer onderzoek nodig van goede methodologische kwaliteit op het gebied van ‘passieve’ zelfzorginterventies. Hulpverleners zouden moet stoppen met het promoten van deze zelfzorginterventies. In plaats daarvan zouden zij actieve zelfzorg meer moeten stimuleren.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatuur

  1. Schwarz K, Mertz W. Chromium(III) and the glucose tolerance factor. Arch Biochem Biophys 2003;85:292-5.

    Google Scholar 

  2. Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 1977;30:531-8.

    Google Scholar 

  3. Sun Y, Ramirez J, Woski SA, Vincent JB. The binding of trivalent chromium to low-molecular-weight chromium-binding substance (LMWCr) and the transfer of chromium from transferrin and chromium picolinate to LMWCr. J Biol Inorg Chem 2000;5:129-36.

    Google Scholar 

  4. Davis CM, Vincent JB. Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry 1997;36:4382-5.

    Google Scholar 

  5. Anderson RA, Cheng N, Bryden NA, Polansky MM, Chi J, Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 1997;46:1786-91.

    Google Scholar 

  6. Pittler MH, Stevinson C, Ernst E. Chromium picolinate for reducing body weight: meta-analysis of randomised trials. Int J Obes Relat Metab Disord 2003;27:522-9.

    Google Scholar 

  7. Lai MH. Antioxidant effects and insulin resistance improvement of chromium combined with vitamin C and e supplementation for mellitus. J Clin Biochem Nutr 2008;43:191-8.

    Google Scholar 

  8. Albarracin C, Fuqua B, Geohas J, Juturu V, Finch MR, Komorowski JR. Combination of chromium and biotin improves coronary risk factors in hypercholesterolemic type-2-diabetes mellitus: a placebo-controlled, double-blind randomized clinical trial. J Cardiometab Syndr 2007;2:91-7.

    Google Scholar 

  9. Albarracin CA, Fuqua BC, Evans JL, Goldfine ID. Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type-2-diabetes. Diabetes Metab Res Rev 2008;24:41-51.

    Google Scholar 

  10. Geohas J, Daly A, Juturu V, Finch M, Komorowski JR. Chromium picolinate and biotin combination reduces atherogenic index of plasma in patients with type-2-diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial. Am J Med Sci 2007;333:145-53.

    Google Scholar 

  11. Singer GM, Geohas J. The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type-2-diabetes mellitus: a placebo-controlled, double-blinded, randomized trial. Diabetes Technol Ther 2006;8:636-43.

    Google Scholar 

  12. Jarvill-Taylor KJ, Anderson RA, Graves DJ. A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes. J Am Coll Nutr 2001;20:327-36.

    Google Scholar 

  13. Imparl-Radosevich J, Deas S, Polansky MM, Baedke DA, Ingebritsen TS, Anderson RA, et al. Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling. Horm Res 1998;50:177-82.

    Google Scholar 

  14. Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type-2-diabetes. Diabetes Care 2003;26:3215-8.

    Google Scholar 

  15. Solomon TP, Blannin AK. Changes in glucose tolerance and insulin sensitivity following 2 weeks of daily cinnamon ingestion in healthy humans. Eur J Appl Physiol 2009;105:969-76.

    Google Scholar 

  16. Hlebowicz J, Hlebowicz A, Lindstedt S, Björgell O, Höglund P, Holst JJ, et al. Effects of 1 and 3 g cinnamon on gastric emptying, satiety, and postprandial blood glucose, insulin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and ghrelin concentrations in healthy subjects. Am J Clin Nutr 2009;89:815-21.

    Google Scholar 

  17. Ziegenfuss TN, Hofheins JE, Mendel RW, Landis J, Anderson RA. Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr 2006;3:45-53.

    Google Scholar 

  18. Solomon TP, Blannin AK. Effects of short-term cinnamon ingestion on in vivo glucose tolerance. Diabetes Obes Metab 2007;9:895-901.

    Google Scholar 

  19. Baker WL, Gutierrez-Williams G, White CM, Kluger J, Coleman CI. Effect of cinnamon on glucose control and lipid parameters. Diabetes Care 2008;31:41-3.

    Google Scholar 

  20. Suppapitiporn S, Kanpaksi N, Suppapitiporn S. The effect of cinnamon cassia powder in type-2-diabetes mellitus. J Med Assoc Thai 2006;89 Suppl 3:S200-5.

    Google Scholar 

  21. Blevins SM, Leyva MJ, Brown J, Wright J, Scofield RH, Aston CE. Effect of cinnamon on glucose and lipid levels in non insulin-dependent type-2-diabetes. Diabetes Care.2007;30:2236-7.

    Google Scholar 

  22. Hlebowicz J, Darwiche G, Björgell O, Almér LO. Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects. Am J Clin Nutr 2007;85:1552-6.

    Google Scholar 

  23. Brook RD, Julius S. Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens 2000;13(6 Pt 2):112S-122S.

    Google Scholar 

  24. Pitzalis MV, Mastropasqua F, Massari F, Passantino A, Colombo R, Mannarini A, et al. Effect of respiratory rate on the relationships between RR interval and systolic blood pressure fluctuations: a frequency-dependent phenomenon. Cardiovasc Res 1998;38:332-9.

    Google Scholar 

  25. Lanfranchi PA, Somers VK. Arterial baroreflex function and cardiovascular variability: interactions and implications. Am J Physiol Regul Integr Comp Physiol 2002;283:R815-26.

    Google Scholar 

  26. Parati G, Carretta R. Device-guided slow breathing as a non-pharmacological approach to antihypertensive treatment: efficacy, problems and perspectives. J Hypertens 2007;25:57-61.

    Google Scholar 

  27. Schein MH, Gavish B, Baevsky T, Kaufman M, Levine S, Nessing A, et al. Treating hypertension in type II diabetic patients with device-guided breathing: a randomized controlled trial. J Hum Hypertens 2009;23:325-31.

    Google Scholar 

  28. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM, et al. Tests of glycemia in diabetes. Diabetes Care 2004;27:1761-73.

    Google Scholar 

  29. Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA, et al. Self-monitoring of blood glucose in patients with type-2-diabetes who are not using insulin. Cochrane Database Syst Rev 2005;18(2):CD005060.

    Google Scholar 

  30. Welschen LM, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA, et al. Self-monitoring of blood glucose in patients with type-2-diabetes who are not using insulin: a systematic review. Diabetes Care 2005;28:1510-7.

    Google Scholar 

  31. Davidson MB. Self-monitoring of blood glucose in patients with type-2-diabetes who are not using insulin: response to Welschen et al. and Kleefstra et al. Diabetes Care 2005;28:2597; author reply 2597-8.

Download references

Author information

Authors and Affiliations

  1. www.bsl.nl/shop/bijblijven-0168-9428.html

    N. Kleefstra

Authors
  1. N. Kleefstra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. T. Houweling
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Arts-onderzoeker, Diabetes kenniscentrum, Isala klinieken, Zwolle; Langerhans Medical Research Group, Zwolle

Huisarts, Langerhans Medical Research Group, Zwolle; Huisartsenpraktijk Houweling en Hoogstraten, Sleeuwijk

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kleefstra, N., Houweling, S.T. Zelfzorginterventies bij patiënten met diabetes mellitus type 2. BIJB 26, 71–77 (2010). https://doi.org/10.1007/BF03088756

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03088756

Search

Navigation